Icon Plc (ICLR): who owns it and who trades it
As of Nov 16, 2026, ICLR insiders reported 47 open-market sales worth $7.8M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Ciaran Murray (Director), with $3.2M. 8 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Icon
From the latest filingsOverall: more selling than buying. Insiders and Congress mostly sold. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, ICLR insiders reported $0 of open-market purchases and $7.8M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Ciaran Murray | Director | Sale | 10,000 | $200.18 | $2M | Form 4 |
| Nov 2, 2026 | Ciaran Murray | Director | Sale | 3,452 | $205.66 | $710K | Form 4 |
| Nov 2, 2026 | Barry Edward Balfe | CEO | Sale | 1,053 | $204.91 | $216K | Form 4 |
| Nov 2, 2026 | Barry Edward Balfe | CEO | Sale | 1,509 | $206.15 | $311K | Form 4 |
| Nov 2, 2026 | Barry Edward Balfe | CEO | Sale | 1,224 | $207.16 | $254K | Form 4 |
| Nov 2, 2026 | Barry Edward Balfe | CEO | Sale | 1,314 | $208.00 | $273K | Form 4 |
| Nov 2, 2026 | Barry Edward Balfe | CEO | Sale | 75 | $209.53 | $15.7K | Form 4 |
| Nov 2, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 303 | $204.91 | $62.1K | Form 4 |
| Nov 2, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 434 | $206.15 | $89.5K | Form 4 |
| Nov 2, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 352 | $207.16 | $72.9K | Form 4 |
| Nov 2, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 377 | $208.00 | $78.4K | Form 4 |
| Nov 2, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 22 | $209.53 | $4.6K | Form 4 |
| Nov 2, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 54 | $204.91 | $11.1K | Form 4 |
| Nov 2, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 76 | $206.15 | $15.7K | Form 4 |
| Nov 2, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 63 | $207.16 | $13.1K | Form 4 |
| Nov 2, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 67 | $208.00 | $13.9K | Form 4 |
| Nov 2, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 4 | $209.53 | $838 | Form 4 |
| Oct 23, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 42 | $180.54 | $7.6K | Form 4 |
| Oct 23, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 81 | $181.39 | $14.7K | Form 4 |
| Oct 23, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 43 | $182.30 | $7.8K | Form 4 |
| Oct 23, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 52 | $183.42 | $9.5K | Form 4 |
| Oct 23, 2026 | Emer Lyons | Chief Accounting Officer | Sale | 54 | $184.29 | $10K | Form 4 |
| Sep 17, 2026 | Eugene Pacelli McCague | Director | Sale | 3,255 | $175.00 | $570K | Form 4 |
| Sep 17, 2026 | Ronan Martin Murphy | Director | Sale | 5,005 | $175.00 | $876K | Form 4 |
| Sep 16, 2026 | John Dr Climax | Director | Sale | 5,005 | $175.00 | $876K | Form 4 |
| Aug 11, 2026 | Anne Clem Whitaker | Director | Sale | 88 | $162.72 | $14.3K | Form 4 |
| Aug 11, 2026 | Anne Clem Whitaker | Director | Sale | 96 | $163.77 | $15.7K | Form 4 |
| Aug 11, 2026 | Anne Clem Whitaker | Director | Sale | 67 | $165.51 | $11.1K | Form 4 |
| Aug 11, 2026 | Anne Clem Whitaker | Director | Sale | 590 | $164.47 | $97K | Form 4 |
| Aug 11, 2026 | Julie O'Neill | Director | Sale | 73 | $165.51 | $12.1K | Form 4 |
| Aug 11, 2026 | Julie O'Neill | Director | Sale | 95 | $162.72 | $15.5K | Form 4 |
| Aug 11, 2026 | Julie O'Neill | Director | Sale | 105 | $163.77 | $17.2K | Form 4 |
| Aug 11, 2026 | Julie O'Neill | Director | Sale | 642 | $164.47 | $106K | Form 4 |
| Aug 11, 2026 | Ciaran Murray | Director | Sale | 1,880 | $164.47 | $309K | Form 4 |
| Aug 11, 2026 | Ciaran Murray | Director | Sale | 212 | $165.51 | $35.1K | Form 4 |
| Aug 11, 2026 | Ciaran Murray | Director | Sale | 305 | $163.77 | $49.9K | Form 4 |
| Aug 11, 2026 | Ciaran Murray | Director | Sale | 280 | $162.72 | $45.6K | Form 4 |
| Aug 11, 2026 | Linda Grais | Director | Sale | 87 | $162.72 | $14.2K | Form 4 |
| Aug 11, 2026 | Linda Grais | Director | Sale | 97 | $163.77 | $15.9K | Form 4 |
| Aug 11, 2026 | John Dr Climax | Director | Sale | 95 | $163.77 | $15.6K | Form 4 |
| Aug 11, 2026 | John Dr Climax | Director | Sale | 591 | $164.47 | $97.2K | Form 4 |
| Aug 11, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 180 | $165.51 | $29.8K | Form 4 |
| Aug 11, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 1,591 | $164.47 | $262K | Form 4 |
| Aug 11, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 237 | $162.72 | $38.6K | Form 4 |
| Aug 11, 2026 | Nigel Bernard John Clerkin | CFO | Sale | 259 | $163.77 | $42.4K | Form 4 |
| Aug 10, 2026 | Barry Edward Balfe | CEO | Sale | 304 | $163.80 | $49.8K | Form 4 |
| Aug 10, 2026 | Barry Edward Balfe | CEO | Sale | 78 | $165.14 | $12.9K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Ciaran Murray | Director | – | $3.2M | Nov 12, 2026 |
| Barry Edward Balfe | Chief Executive Officer, Director | – | $1.1M | Nov 2, 2026 |
| John Dr Climax | Director | – | $989K | Sep 16, 2026 |
| Ronan Martin Murphy | Director | – | $876K | Sep 17, 2026 |
| Nigel Bernard John Clerkin | Chief Financial Officer | – | $680K | Nov 2, 2026 |
| Eugene Pacelli McCague | Director | – | $570K | Sep 17, 2026 |
| Julie O'Neill | Director | – | $150K | Aug 11, 2026 |
| Anne Clem Whitaker | Director | – | $138K | Aug 11, 2026 |
| Emer Lyons | Chief Accounting Officer | – | $104K | Nov 2, 2026 |
| Linda Grais | Director | – | $30K | Aug 11, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ICLR short interest
2.37M ICLR shares are sold short. Over the last 12 reports the number of shares short went down 28%.
As of Oct 30, 2026, 2.37M ICLR shares were sold short, down 20.0% from the report before. At the average daily volume of 1.40M shares, buying them all back would take about 1.7 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.37M | – | -20% | 1.40M | 1.7 |
| Oct 15, 2026 | 2.97M | – | +6% | 799,916 | 3.7 |
| Sep 30, 2026 | 2.80M | – | +7% | 1.10M | 2.5 |
| Sep 15, 2026 | 2.63M | – | +10% | 948,045 | 2.8 |
| Aug 31, 2026 | 2.38M | – | +7% | 475,293 | 5.0 |
| Aug 14, 2026 | 2.22M | – | -0% | 638,274 | 3.5 |
| Jul 31, 2026 | 2.22M | – | -14% | 963,379 | 2.3 |
| Jul 15, 2026 | 2.60M | 3.39% | -13% | 610,687 | 4.2 |
| Jun 30, 2026 | 2.99M | 3.91% | -8% | 1.24M | 2.4 |
| Jun 15, 2026 | 3.24M | 4.23% | +8% | 1.11M | 2.9 |
| May 29, 2026 | 3.01M | 3.93% | -9% | 1.19M | 2.5 |
| May 15, 2026 | 3.29M | 4.30% | +23% | 937,639 | 3.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded ICLR
Since Nov 17, 2024, 2 members of Congress reported 0 purchases and 3 sales of ICLR. The latest was a sale by Kevin Hern on Aug 14, 2026, reported Sep 1, 2026.
Purchases 0Sales 3
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Kevin Hern (R-OK) | Partial sale | $15K–$50K | Joint | Sep 1, 2026 | Report |
| Mar 5, 2026 | Kevin Hern (R-OK) | Sale | $100K–$250K | Joint | Apr 3, 2026 | Report |
| Feb 12, 2026 | Julia Letlow (R-LA) | Sale | $1K–$15K | Self | Mar 12, 2026 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Icon financials
Famous investors that hold ICLR
8 of the 50 well-known investors we track reported holding ICLR in their latest 13F filing. The largest position is Bill Nygren's, worth $823M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Bill Nygren · Harris Associates (Oakmark) | Q3 2026 | 4.84M | $823M | 1.1% | +8% |
| Edgar Wachenheim · Greenhaven Associates | Q3 2026 | 3.07M | $522M | 6.6% | -1% |
| Glenn Greenberg · Brave Warrior Advisors | Q3 2026 | 2.84M | $482M | 11.2% | -10% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 332,975 | $56.6M | 0.1% | -9% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 134,364 | $22.8M | 0.1% | New |
| Israel Englander · Millennium Management | Q3 2026 | 80,862 | $13.7M | 0.0% | +67% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 11,500 | $2M | 0.0% | +156% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 2,942 | $500K | 0.0% | -89% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named ICLR in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Wellington Management Group LLP | 13G/A | 3.2% |
| Nov 16, 2026 | Wellington Management Group LLP | 13G/A | 3.2% |
| Nov 5, 2026 | FMR LLC | 13G/A | 8.5% |
| Nov 5, 2026 | FMR LLC | 13G/A | 8.5% |
Questions about Icon Plc (ICLR) stock
Are ICLR insiders buying or selling?
In the last 12 months, ICLR insiders reported no open-market purchases and 47 sales worth $7.8M. The latest trade was on Nov 12, 2026. See every trade.
What is the short interest in ICLR?
As of Oct 30, 2026, 2.37M ICLR shares were sold short, down 20.0% from the report before. At the average daily volume of 1.40M shares, buying them all back would take about 1.7 trading days (days to cover). See the history.
Have members of Congress traded ICLR?
Yes. 2 members of Congress reported 0 purchases and 3 sales of ICLR since Nov 17, 2024. The latest was reported on Sep 1, 2026. See the trades.
Which famous investors hold ICLR?
8 of the 50 well-known investors we track reported ICLR in their latest 13F filing, including Bill Nygren, Edgar Wachenheim, Glenn Greenberg. The largest position is worth $823M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.